Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 312

1.

The burden of cutaneous adnexal carcinomas and the risk of associated squamous cell carcinoma: a population-based study.

De Giorgi V, Salvati L, Barchielli A, Caldarella A, Gori A, Scarfì F, Savarese I, Pimpinelli N, Urso C, Massi D.

Br J Dermatol. 2018 Oct 16. doi: 10.1111/bjd.17321. [Epub ahead of print]

PMID:
30328107
2.

ΜelanoQ: A Consensus Questionnaire of Standardized Epidemiologic and Clinical Variables for Melanoma Risk Assessment by the MelaNostrum Consortium.

Stratigos AJ, Fargnoli MC, De Nicolo A, Peris K, Puig S, Soura E, Menin C, Calista D, Ghiorzo P, Mandala M, Massi D, Rodolfo M, Del Regno L, Stefanaki I, Gogas H, Bataille V, Tucker MA, Whiteman D, Nagore E, Landi MT.

J Eur Acad Dermatol Venereol. 2018 Aug 10. doi: 10.1111/jdv.15208. [Epub ahead of print]

PMID:
30098061
3.

Clinical and Dermoscopic Features of Lichenoid Keratosis: A Retrospective Case Study.

Gori A, Oranges T, Janowska A, Savarese I, Chiarugi A, Nardini P, Salvati L, Maria Palleschi G, Scarfì F, Massi D, Innocenti A, Covarelli P, De Giorgi V.

J Cutan Med Surg. 2018 Nov/Dec;22(6):561-566. doi: 10.1177/1203475418786213. Epub 2018 Jul 18.

PMID:
30016886
4.

Improved label-free diagnostics and pathological assessment of atherosclerotic plaques through nonlinear microscopy.

Baria E, Nesi G, Santi R, Maio V, Massi D, Pratesi C, Cicchi R, Pavone FS.

J Biophotonics. 2018 Jun 22:e201800106. doi: 10.1002/jbio.201800106. [Epub ahead of print]

PMID:
29931805
5.

At the Root: Cutaneous Langerhans Cell Histiocytosis.

Maglie R, Vannucchi M, Quintarelli L, Caproni M, Massi D, Antiga E.

Am J Med. 2018 Aug;131(8):922-926. doi: 10.1016/j.amjmed.2018.04.015. Epub 2018 May 2. No abstract available.

PMID:
29729245
6.

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma.

Audrito V, Managò A, Zamporlini F, Rulli E, Gaudino F, Madonna G, D'Atri S, Antonini Cappellini GC, Ascierto PA, Massi D, Raffaelli N, Mandalà M, Deaglio S.

Oncotarget. 2018 Apr 10;9(27):18997-19005. doi: 10.18632/oncotarget.24871. eCollection 2018 Apr 10.

7.

Correction to: Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases.

Pizzichetta MA, Massi D, Mandalà M, Queirolo P, Stanganelli I, De Giorgi V, Ghigliotti G, Cavicchini S, Quaglino P, Corradin MT, Rubegni P, Alaibac M, Astorino S, Ayala F, Magi S, Mazzoni L, Manganoni MA, Talamini R, Serraino D, Palmieri G; Italian Melanoma Intergroup (IMI).

J Transl Med. 2018 Feb 20;16(1):33. doi: 10.1186/s12967-018-1408-8.

8.

ECCO essential requirements for quality cancer care: Melanoma.

Wouters MW, Michielin O, Bastiaannet E, Beishon M, Catalano O, Del Marmol V, Delgado-Bolton R, Dendale R, Trill MD, Ferrari A, Forsea AM, Kreckel H, Lövey J, Luyten G, Massi D, Mohr P, Oberst S, Pereira P, Prata JPP, Rutkowski P, Saarto T, Sheth S, Spurrier-Bernard G, Vuoristo MS, Costa A, Naredi P.

Crit Rev Oncol Hematol. 2018 Feb;122:164-178. doi: 10.1016/j.critrevonc.2017.12.020. Epub 2018 Jan 2. Review.

9.

Venous outlet syndrome caused by capillary hemangioma of the subclavian vein.

Bongiolatti S, Massi D, Maio V, Gonfiotti A, Viggiano D, Voltolini L.

Asian Cardiovasc Thorac Ann. 2018 Mar;26(3):224-226. doi: 10.1177/0218492318760693. Epub 2018 Feb 14.

PMID:
29444598
10.

Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma.

Audrito V, Managò A, La Vecchia S, Zamporlini F, Vitale N, Baroni G, Cignetto S, Serra S, Bologna C, Stingi A, Arruga F, Vaisitti T, Massi D, Mandalà M, Raffaelli N, Deaglio S.

J Natl Cancer Inst. 2018 Mar 1;110(3). doi: 10.1093/jnci/djx198.

PMID:
29309612
11.

Clinicopathological predictors of recurrence in nodular and superficial spreading cutaneous melanoma: a multivariate analysis of 214 cases.

Pizzichetta MA, Massi D, Mandalà M, Queirolo P, Stanganelli I, De Giorgi V, Ghigliotti G, Cavicchini S, Quaglino P, Corradin MT, Rubegni P, Alaibac M, Astorino S, Ayala F, Magi S, Mazzoni L, Manganoni MA, Talamini R, Serraino D, Palmieri G; Italian Melanoma Intergroup (IMI).

J Transl Med. 2017 Nov 7;15(1):227. doi: 10.1186/s12967-017-1332-3. Erratum in: J Transl Med. 2018 Feb 20;16(1):33.

12.

Bullous eruption in a patient with B-cell chronic lymphocytic leukemia: a diagnostic challenge.

Maglie R, Antiga E, Vannucchi M, Del Bianco E, Bianchi B, Massi D, Caproni M.

Int J Dermatol. 2017 Dec;56(12):1445-1447. doi: 10.1111/ijd.13807. Epub 2017 Oct 26. No abstract available.

PMID:
29076242
13.

mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition.

Xue G, Kohler R, Tang F, Hynx D, Wang Y, Orso F, Prêtre V, Ritschard R, Hirschmann P, Cron P, Roloff T, Dummer R, Mandalà M, Bichet S, Genoud C, Meyer AG, Muraro MG, Spagnoli GC, Taverna D, Rüegg C, Merghoub T, Massi D, Tang H, Levesque MP, Dirnhofer S, Zippelius A, Hemmings BA, Wicki A.

Oncotarget. 2017 May 25;8(41):69204-69218. doi: 10.18632/oncotarget.18213. eCollection 2017 Sep 19.

14.

Steroid treatment of acute graft-versus-host disease grade I: a randomized trial.

Bacigalupo A, Milone G, Cupri A, Severino A, Fagioli F, Berger M, Santarone S, Chiusolo P, Sica S, Mammoliti S, Sorasio R, Massi D, Van Lint MT, Raiola AM, Gualandi F, Selleri C, Sormani MP, Signori A, Risitano A, Bonifazi F; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Haematologica. 2017 Dec;102(12):2125-2133. doi: 10.3324/haematol.2017.171157. Epub 2017 Sep 29.

15.

Lichen planus triggered by CT-P13 and recurrence during secukinumab treatment.

Maglie R, Di Cesare A, Lazzeri L, Pescitelli L, Ricceri F, Vannucchi M, Massi D, Prignano F.

Br J Dermatol. 2018 Jan;178(1):303-304. doi: 10.1111/bjd.16003. Epub 2017 Dec 29. No abstract available.

PMID:
28940185
16.

Species distribution models of two critically endangered deep-sea octocorals reveal fishing impacts on vulnerable marine ecosystems in central Mediterranean Sea.

Lauria V, Garofalo G, Fiorentino F, Massi D, Milisenda G, Piraino S, Russo T, Gristina M.

Sci Rep. 2017 Aug 14;7(1):8049. doi: 10.1038/s41598-017-08386-z.

17.

New insights into naevoid melanomas: a clinicopathological reassessment.

Cook MG, Massi D, Blokx WAM, Van den Oord J, Koljenović S, De Giorgi V, Kissin E, Grant M, Mandal A, Gremel G, Gaudy C, Viros A, Dhomen N, Khosrotehrani K, Marais R, Green AC, Mihm MC Jr.

Histopathology. 2017 Dec;71(6):943-950. doi: 10.1111/his.13317. Epub 2017 Oct 2.

PMID:
28741688
18.

PI3K-AKT-mTOR inhibition in cancer immunotherapy, redux.

O'Donnell JS, Massi D, Teng MWL, Mandala M.

Semin Cancer Biol. 2018 Feb;48:91-103. doi: 10.1016/j.semcancer.2017.04.015. Epub 2017 May 2. Review.

PMID:
28467889
19.

Rationale for New Checkpoint Inhibitor Combinations in Melanoma Therapy.

Mandalà M, Tondini C, Merelli B, Massi D.

Am J Clin Dermatol. 2017 Oct;18(5):597-611. doi: 10.1007/s40257-017-0282-0. Review.

PMID:
28432648
20.

Kaposi sarcoma in a patient treated with ruxolitinib.

Loscocco GG, Vannucchi M, Paoli C, Franci A, Pieri L, Annunziato F, Massi D, Vannucchi AM.

Ann Oncol. 2017 Jul 1;28(7):1670-1671. doi: 10.1093/annonc/mdx188. No abstract available.

PMID:
28419187

Supplemental Content

Loading ...
Support Center